164 related articles for article (PubMed ID: 29657622)
1. Computed Tomography Assessment of Hepatic Metastases of Breast Cancer with Revised Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1): Inter-Observer Agreement.
Ghobrial FEI; Eldin MS; Razek AAKA; Atwan NI; Shamaa SSA
Pol J Radiol; 2017; 82():593-597. PubMed ID: 29657622
[TBL] [Abstract][Full Text] [Related]
2. Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification.
Razek AAKA; Shamaa S; Lattif MA; Yousef HH
Pol J Radiol; 2017; 82():441-447. PubMed ID: 29662570
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases.
Bellomi M; De Piano F; Ancona E; Lodigiani AF; Curigliano G; Raimondi S; Preda L
Eur J Radiol; 2017 Oct; 95():96-101. PubMed ID: 28987705
[TBL] [Abstract][Full Text] [Related]
4. Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.
Sato Y; Watanabe H; Sone M; Onaya H; Sakamoto N; Osuga K; Takahashi M; Arai Y;
Ups J Med Sci; 2013 Mar; 118(1):16-22. PubMed ID: 23167460
[TBL] [Abstract][Full Text] [Related]
5. Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer.
Jang GS; Kim MJ; Ha HI; Kim JH; Kim HS; Ju SB; Zang DY
Chin J Cancer Res; 2013 Dec; 25(6):689-94. PubMed ID: 24385696
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy.
He H; Cai C; Charnsangavej C; Theriault RL; Green M; Quraishi MA; Yang WT
Can Assoc Radiol J; 2015 Nov; 66(4):356-62. PubMed ID: 26165625
[TBL] [Abstract][Full Text] [Related]
7. Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.
Fledelius J; Khalil A; Hjorthaug K; Frøkiær J
EJNMMI Res; 2016 Dec; 6(1):71. PubMed ID: 27655428
[TBL] [Abstract][Full Text] [Related]
8. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
[TBL] [Abstract][Full Text] [Related]
9. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
[TBL] [Abstract][Full Text] [Related]
10. CT-based whole-body tumor volumetry versus RECIST 1.1: Feasibility and implications for inter-reader variability.
Zimmermann M; Kuhl CK; Engelke H; Bettermann G; Keil S
Eur J Radiol; 2021 Feb; 135():109514. PubMed ID: 33401109
[TBL] [Abstract][Full Text] [Related]
11. Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer.
Huicochea Castellanos S; Pagano A; Plodkowski AJ; Girshman J; Hellmann MD; Rizvi H; Flynn J; Zheng J; Capanu M; Halpenny DF; Ginsberg MS
Lung Cancer; 2021 Nov; 161():60-67. PubMed ID: 34536733
[TBL] [Abstract][Full Text] [Related]
12. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
Liu K; Li G; Fan C; Zhou C; Li J
Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
[TBL] [Abstract][Full Text] [Related]
13. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
[TBL] [Abstract][Full Text] [Related]
14. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
Zacchino M; Bonaffini PA; Corso A; Minetti V; Nasatti A; Tinelli C; Dore R; Calliada F; Sironi S
Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427
[TBL] [Abstract][Full Text] [Related]
15. The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases.
Schiavon G; Ruggiero A; Bekers DJ; Barry PA; Sleijfer S; Kloth J; Krestin GP; Schöffski P; Verweij J; Mathijssen RH
Eur J Cancer; 2014 Mar; 50(5):972-80. PubMed ID: 24480402
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Volumetric versus Manual Measurement in Disseminated Testicular Cancer; No Difference in Assessment between Non-Radiologists and Genitourinary Radiologist.
Öztürk Ç; Velleman T; Bongaerts AH; Bergman LM; van Ginkel RJ; Gietema JA; Hoekstra HJ
PLoS One; 2017; 12(1):e0168977. PubMed ID: 28081195
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study.
Gouel P; Callonnec F; Levêque É; Valet C; Blôt A; Cuvelier C; Saï S; Saunier L; Pepin LF; Hapdey S; Libraire J; Vera P; Viard B
Sci Rep; 2023 Jun; 13(1):9148. PubMed ID: 37277412
[TBL] [Abstract][Full Text] [Related]
18. Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1.
Muenzel D; Engels HP; Bruegel M; Kehl V; Rummeny EJ; Metz S
Radiol Oncol; 2012 Mar; 46(1):8-18. PubMed ID: 22933974
[TBL] [Abstract][Full Text] [Related]
19. Inter-observer agreement in GTV delineation of bone metastases on CT and impact of MR imaging: A multicenter study.
Gerlich AS; van der Velden JM; Kotte ANTJ; Tseng CL; Fanetti G; Eppinga WSC; Kasperts N; Intven MPW; Pameijer FA; Philippens MEP; Verkooijen HM; Seravalli E
Radiother Oncol; 2018 Mar; 126(3):534-540. PubMed ID: 28919003
[TBL] [Abstract][Full Text] [Related]
20. The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
Abramson RG; Lakomkin N; Hainline A; Kang H; Hutson MS; Arteaga CL
AJR Am J Roentgenol; 2018 Jan; 210(1):W1-W7. PubMed ID: 29064750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
